CN108543044B - 一种治疗痤疮的联合用药物及其用途 - Google Patents
一种治疗痤疮的联合用药物及其用途 Download PDFInfo
- Publication number
- CN108543044B CN108543044B CN201810524286.1A CN201810524286A CN108543044B CN 108543044 B CN108543044 B CN 108543044B CN 201810524286 A CN201810524286 A CN 201810524286A CN 108543044 B CN108543044 B CN 108543044B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- product
- prepared
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 206010000496 acne Diseases 0.000 title claims abstract description 33
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 30
- 239000000047 product Substances 0.000 claims abstract description 32
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 239000013588 oral product Substances 0.000 claims abstract description 11
- 229940023486 oral product Drugs 0.000 claims abstract description 11
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 3
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 241000382455 Angelica sinensis Species 0.000 claims description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims description 8
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- 244000248825 Peltandra virginica Species 0.000 claims description 8
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 8
- 244000274050 Platycodon grandiflorum Species 0.000 claims description 8
- 235000008599 Poria cocos Nutrition 0.000 claims description 8
- 244000179560 Prunella vulgaris Species 0.000 claims description 8
- 235000017803 cinnamon Nutrition 0.000 claims description 8
- 235000008113 selfheal Nutrition 0.000 claims description 8
- 244000144730 Amygdalus persica Species 0.000 claims description 7
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 7
- 244000182216 Mimusops elengi Species 0.000 claims description 7
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 7
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 7
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 7
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 7
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 7
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 7
- 244000273928 Zingiber officinale Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims description 6
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 6
- 244000170916 Paeonia officinalis Species 0.000 claims description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 6
- 244000131316 Panax pseudoginseng Species 0.000 claims description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 6
- 235000009165 saligot Nutrition 0.000 claims description 6
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 claims description 5
- 241000159213 Zygophyllaceae Species 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 230000001815 facial effect Effects 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 2
- 244000299790 Rheum rhabarbarum Species 0.000 claims 1
- 229940000425 combination drug Drugs 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 206010040882 skin lesion Diseases 0.000 abstract description 10
- 231100000444 skin lesion Toxicity 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 9
- 238000011084 recovery Methods 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 4
- 229940025703 topical product Drugs 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000037380 skin damage Effects 0.000 description 8
- 244000077995 Coix lacryma jobi Species 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000006751 Platycodon Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 229930189914 platycodon Natural products 0.000 description 6
- 206010033733 Papule Diseases 0.000 description 5
- 244000046146 Pueraria lobata Species 0.000 description 5
- 235000010575 Pueraria lobata Nutrition 0.000 description 5
- 241000219061 Rheum Species 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 206010054107 Nodule Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- 208000029561 pustule Diseases 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000132585 Centaurea calcitrapa Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 238000012313 Kruskal-Wallis test Methods 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010054786 Skin burning sensation Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241001521901 Tribulus lanuginosus Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种治疗痤疮的联合用药物及其用途,所述联合用药物是由内服产品和外用产品组成;所述内服产品是由肉桂、干姜、薏苡仁、当归、葛根、枸杞子、茯苓、桔梗制备而成;所述外用产品是由当归、黄芩、连翘、皂角刺、夏枯草、大黄、薏苡仁、金银花、丹参、赤芍、蒺藜、黄精、灵芝、三七、红花、桃仁制备而成。临床实验结果表明,本发明的产品使用前后痤疮症状具有显著差异,说明本发明产品组合具有疏风清热、解毒散结、活血化瘀的功用,对痤疮治疗及促进皮损恢复具有明显疗效。并且采用内外同治的方法,可以缩短痤疮治疗周期,增强痤疮治疗效果。
Description
技术领域
本发明涉及一种治疗痤疮的联合用药物及其用途。
背景技术
痤疮是毛囊皮脂腺单位的一种慢性炎症性皮肤病,从新生儿到成人,几乎所有年龄段的人均可患病,临床表现以好发于面部的粉刺、丘疹、脓疱、结节等多形性皮损为特点。全世界所有地区痤疮的患病率在70%-87%之间。
目前,治疗痤疮的西医疗法主要针对病因学采取如下几类方法,①抑制局部炎症:口服及外用抗菌素如四环素、美满霉素、甲硝唑等;②抗雄激素:口服雌激素、黄体酮、安体舒通等;③抑制皮脂腺分泌,改善毛囊口角化过度:如用维甲酸、硫酸锌等;以上疗法均具有一定的疗效,但采用西药治疗容易出现耐药性,出现许多副作用,如口干、口唇脱皮、皮肤干燥瘙痒,胃肠道反应等,育龄期妇女服用还会发生畸胎。
因此,现在急需一种能够有效治疗痤疮,并且安全无副作用的药物。
发明内容
本发明的目的在于提供一种治疗痤疮的联合用药物,它是由内服产品和外用产品组成;所述内服产品是由肉桂、干姜、薏苡仁、当归、葛根、枸杞子、茯苓、桔梗制备而成;所述外用产品是由当归、酒黄芩、连翘、皂角刺、夏枯草、酒大黄、薏苡仁、金银花、丹参、赤芍、炒蒺藜、制黄精、灵芝、三七、红花、桃仁制备而成。
进一步地,所述内服产品是由下述重量配比的原料制备而成:
肉桂5~30份、干姜10~27份、薏苡仁15~50份、当归1~10份、葛根10~60份、枸杞子10~40份、茯苓15~45份、桔梗9~36份、砂仁6~24份。
进一步地,所述内服产品是由下述重量配比的原料制备而成:
肉桂15份、干姜15份、薏苡仁30份、当归3份、葛根30份、枸杞子20份、茯苓30份、桔梗15份、砂仁10份。
进一步地,所述内服产品是由原料药的药粉、原料药的水提取物或有机溶剂提取物为活性成分,加上药学和/或食品上可接受的辅料制备而成的制剂。
进一步地,所述制剂为汤剂、散剂、胶囊剂、片剂、颗粒剂、羹剂。
进一步地,所述外用产品是由下述重量配比的原料制备而成:
当归11~55份、酒黄芩5~30份、连翘9~30份、皂角刺10~40份、夏枯草5~50份、酒大黄3~27份、薏苡仁10~60份、金银花3~35份、丹参5~50份、赤芍5~40份、炒蒺藜3~40份、制黄精6~36份、灵芝0.5~15份、三七10~40份、红花15~45份、桃仁10~50份。
进一步地,所述外用产品是由下述重量配比的原料制备而成:
当归30份、酒黄芩15份、连翘15份、皂角刺30份、夏枯草30份、酒大黄15份、薏苡仁30份、金银花15份、丹参30份、赤芍20份、炒蒺藜20份、制黄精20份、灵芝1份、三七30份、红花30份、桃仁30份。
进一步地,所述外用产品是由原料药的粉末、原料药的水提取物或有机溶剂提取物为活性成分,加上化妆品中可接受的辅料制备而成的化妆品。
进一步地,所述外用产品为净面巾、爽肤水、乳液、精华液、面霜、面膜、眼膜、啫喱等。
本发明还提供了上述联合用药物在制备治疗或改善痤疮的食品、保健品、药品或化妆品中的用途。
本发明内服产品以肉桂、干姜、葛根为君扶助脾阳以助化湿臣以茯苓、薏苡仁利水渗湿健脾,砂仁化湿行气,当归养血活血,枸杞子补肾益精血,佐以桔梗载药上升饮药直达病所,诸药合用共奏助阳化湿,活血行气之功。本发明外用产品以银花、连翘疏散风热,清热解毒,皂角刺托毒排脓,活血消痈,夏枯草清热泻火,散结消肿,以上四位为君,黄芩清热燥湿,泻火解毒,酒大黄泻下攻积、逐淤通经、清热泻火,当归补血调经,润肠通便,薏苡仁利水渗湿,健脾除痹,丹参、赤芍清热凉血、除烦安神,蒺藜平肝疏风,黄精消食健胃、益肺脾肾,灵芝补气健脾,三七、红花、桃仁活血化瘀、祛瘀止痛,以上十三位为臣,诸药合用共奏疏风清热、解毒散结、活血化瘀之功。
根据本实验结果可知,用药前后痤疮症状具有显著差异,说明本发明的产品具有疏风清热、解毒散结、活血化瘀的功用,对痤疮治疗及促进皮损恢复具有明显疗效。并且本发明采用内外同治的方法,可以缩短痤疮治疗周期,增强痤疮治疗效果。
本发明的外用产品和内服产品可以单独使用,也可以以任意比例组合使用。
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。
具体实施方式
实施例1、本发明内服产品的制备
1.配方:肉桂15g、干姜15 g、薏苡仁30 g、当归3 g、葛根30 g、枸杞子20 g、茯苓30g、桔梗15 g、砂仁10 g。
2.制备方法:按配方称取原料药,加10-15倍水浸泡15分钟进行预处理;煎煮提取2-4次,每次15-30min,每次煎煮后过滤得滤液,混合所有滤液静止20h,将上清液浓缩至相对密度为1.15-1.3的稠膏;进风温度为180-200℃、出风温度为90-100℃,喷雾干燥得提取物。
将上述900g提取物,加入900g麦芽糊精,200g麦芽糖粉,240g 90%乙醇混合,置于摇摆制粒机中过20目筛,进行制粒,50℃干燥8h,干燥后物料经振荡筛选整粒,取20-60目之间颗粒,按20g/袋分装,即得本发明内服产品。
3.使用方法:每日服用两次,每次一袋,饭后温水冲服。
实施例2、本发明内服产品的制备
1.配方:肉桂30g、干姜27g、薏苡仁50g、当归10 g、葛根60 g、枸杞子40 g、茯苓45g、桔梗36g、砂仁24 g。
2.制备方法:按配方称取原料药,加10-15倍水浸泡15分钟进行预处理;煎煮提取2-4次,每次15-30min,每次煎煮后过滤得滤液,混合所有滤液静止20h,将上清液浓缩至相对密度为1.15-1.3的稠膏;进风温度为180-200℃、出风温度为90-100℃,喷雾干燥得提取物。
将上述450g提取物,加入450g麦芽糊精,100g麦芽糖粉, 120g 90%乙醇混合,置于摇摆制粒机中过20目筛,进行制粒,50℃干燥8h,干燥后物料经振荡筛选整粒,取20-60目之间颗粒,按20g/袋分装,即得本发明内服产品。
3.使用方法:同实施例1。
实施例3、本发明内服产品的制备
1.配方:肉桂5g、干姜10 g、薏苡仁15g、当归1 g、葛根10 g、枸杞子10 g、茯苓15g、桔梗9g、砂仁6 g。
2.制备方法:按配方称取原料药,加10-15倍水浸泡15分钟进行预处理;煎煮提取2-4次,每次15-30min,每次煎煮后过滤得滤液,混合所有滤液静止20h,将上清液浓缩至相对密度为1.15-1.3的稠膏;稠膏放入烘箱60-65℃进行烘干16h,干燥致不能流动;再置于减压干燥器(65℃,-0.1MPa)中进行减压干燥8小时,彻底干燥得提取物。将上述450g提取物,加入450g麦芽糊精,100g麦芽糖粉, 120g 90%乙醇混合制粒,干燥,按20g/袋分装,即得本发明内服产品。
3.使用方法:同实施例1。
实施例4、本发明外用产品的制备
1.配方:当归30g、酒黄芩15 g、连翘15 g、皂角刺30 g、夏枯草30 g、酒大黄15 g、薏苡仁30 g、金银花15 g、丹参30 g、赤芍20 g、炒蒺藜20 g、制黄精20 g、灵芝1 g、三七30g、红花30 g、桃仁30 g。
2.制备方法:将上述配方药材原料粉碎,按重量配比称取各中药材粉末,按料液比1:10加入蒸馏水,浸泡0.5h,加热回流提取1.5h,提取3次,合并提取液,提取液300目筛过滤,即得中药提取液。
将上述提取物40份,加入3份丙二醇,3份丁二醇,2份乳酸杆菌/豆浆发酵产物滤液,1.5份燕麦碱,0.35份丙烯酰二甲基牛磺酸铵/山嵛醇聚醚-25甲基丙烯酸酯交联聚合物,0.2份辛酰羟肟酸,0.15份透明质酸,0.1份甘草酸二钾,0.1份精氨酸;并以去离子水加至100;由此制备而成精华液,辅以天然绒丝(也叫棉籽绒丝)的布基(载体)成为面膜(洁面巾)。
3.使用方法:一片/日,外敷10分钟后取下。
实施例5、本发明外用产品的制备
1.配方:当归11g、酒黄芩5g、连翘9 g、皂角刺10 g、夏枯草5g、酒大黄27 g、薏苡仁10 g、金银花3g、丹参5 g、赤芍5 g、炒蒺藜3 g、制黄精6g、灵芝0.5 g、三七10 g、红花15 g、桃仁10g。
2.制备方法:同实施例4。
3.使用方法:同实施例4。
实施例6、本发明外用产品的制备
1.配方:当归55g、酒黄芩30 g、连翘30 g、皂角刺40 g、夏枯草50g、酒大黄27g、薏苡仁60g、金银花35g、丹参50 g、赤芍40 g、炒蒺藜40 g、制黄精36g、灵芝15 g、三七40 g、红花45 g、桃仁50g。
2.制备方法:同实施例4。
3.使用方法:同实施例4。
以下通过试验例的方式来说明本发明的有益效果。
试验例1
(1)患者来源
均为四川省第二中医医院门诊部以及社会招募的面部痤疮患者,共计120例,其中男性42例,女性78例,年龄15~45岁。
(2)诊断标准
参照《中国临床皮肤病学》(赵辨主编,江苏科学技术出版社,2009年12月第1版)拟定。
西医诊断及分级标准:
青春期开始发病,好发于面部、上胸及背部等皮脂腺发达部位,对称分布。皮损以丘疹、脓疱、黑头、结节、囊肿为主,伴有皮脂溢出呈慢性经过.临床轻重分级为:
①Ⅰ级:主要皮损为黑头粉刺,散发或多发,炎性丘疹散发。总病灶数10~30个。
②Ⅱ级:主要皮损为粉刺,并有中等数量的丘疹合浅在性脓疱,总病灶数31~50个,局限在面部。
中医证候诊断标准
①风热证
主症:黑头或白头粉刺居多,伴红色丘疹。
次症:颜面潮红,皮肤烘热或灼热,鼻息气热,可有痒痛。舌边尖红,苔薄黄,脉弦数或脉数。
②湿热证
主症:皮肤油腻,以疼痛性丘疹合脓庖为主。
次症:间有结节,或伴口臭,便秘、尿赤,舌质红,苔黄腻,脉滑。
具备以上主症及次症2项以上者,可诊断为该证候。
(3)受试者纳入标准
符合西医诊断及分级标准
符合中医证候诊断标准
符合入选年龄标准(16~45岁)
治疗前30日内未用过与本病相关的内服药物
7天内未用过与本病相关的外用药
签署知情同意书
(4)受试者排除标准
妊娠或哺乳期妇女
过敏体质或对本药及其中的药物成分过敏者
近30日内服用过与本病相关的内服药物
7天内用过治疗本病的药物
合并有心血管、脑血管、肝、肾严重原发性疾病
合并有造血系统疾病,精神病患者
化学物质所致的职业性痤疮,药物所致痤疮
不符合纳入标准的其他病例
(5)治疗方法
治疗组(60例):口服实施例1制备的内服产品(2次/日,每次1包)与外用实施例4制备的外用产品(一片/日,外敷10分钟后取下)。
对照组(60例):口服中药汤剂与外用中药汤剂洗剂(按药材配比,由病人自行抓药熬制)备注:中药来源于四川省中医药科学院中医研究所中药库房采购。
中药口服:肉桂15g、当归3 g、茯苓30 g、桔梗15 g、砂仁10 g。
中药洗剂:当归30g、连翘15 g、薏苡仁30 g、金银花15 g、夏枯草30、
赤芍20、制黄精20 g、桃仁30 g。
(6)临床观察指标
一月为一个疗程,观察服用一月后面部皮损情况,根据表1的症候评分,评定疗效
临床治愈:皮损全部消退,仅留有少许色素,皮损总积分为0分。
显效:皮损大部分消退,皮损总积分减少≥70%,<100%。
有效:皮损部分消退,皮损总积分减少≥30%,<70%。
无效:皮损消退不明显,皮损总积分减少<30%。
(7)疗效判定标准
一月为一个疗程,使用一月后观察面部皮损情况,计算疗效指数=(治疗前积分和-治疗后积分和)/治疗前积分总和,以疗效指数≧30%判定为有效,实验组对照组相比较,两组皮损情况均整体减轻,且差异具有统计学意义(P<0.05),可判定该产品对痤疮治疗及促进皮损恢复有作用。
(8)统计学方法
采用SPSS22.0软件进行统计学分析,所有数据均采用均数±标准差()表示,计量资料用非参数检验比较,Kruskal-Wallis检验,以P>0.05为差异无统计学意义,P<0.05为差异有统计学意义。
(9)治疗结果
根据治疗前与治疗后积分和、疗效指数的比较,该病临床症状在用药前后具有显著差异,说明本产品具有疏风清热、解毒散结、活血化瘀的功用,对痤疮治疗及促进皮损恢复具有明显疗效。
综上,本发明的产品对痤疮治疗及促进皮损恢复具有明显疗效。并且本发明采用内外同治的方法,可以缩短痤疮治疗周期,增强痤疮炎治疗效果,为临床治疗痤疮提供了一种新的选择。
Claims (5)
1.一种治疗痤疮的联合用药物,其特征在于:它是由内服产品和外用产品组成;所述内服产品是由肉桂、干姜、薏苡仁、当归、葛根、枸杞子、茯苓、桔梗、砂仁制备而成;所述外用产品是由当归、酒黄芩、连翘、皂角刺、夏枯草、酒大黄、薏苡仁、金银花、丹参、赤芍、炒蒺藜、制黄精、灵芝、三七、红花、桃仁制备而成;
所述内服产品是由下述重量配比的原料制备而成:
肉桂15份、干姜15份、薏苡仁30份、当归3份、葛根30份、枸杞子20份、茯苓30份、桔梗15份、砂仁10份;
所述外用产品是由下述重量配比的原料制备而成:
当归30份、酒黄芩15份、连翘15份、皂角刺30份、夏枯草30份、酒大黄15份、薏苡仁30份、金银花15份、丹参30份、赤芍20份、炒蒺藜20份、制黄精20份、灵芝1份、三七30份、红花30份、桃仁30份。
2.根据权利要求1所述的联合用药物,其特征在于:所述内服产品是由原料药的药粉、原料药的水提取物或有机溶剂提取物为活性成分,加上药学上可接受的辅料制备而成的制剂。
3.根据权利要求2所述的联合用药物,其特征在于:所述制剂为颗粒剂。
4.根据权利要求1所述的联合用药物,其特征在于:所述外用产品是由原料药的粉末、原料药的水提取物或有机溶剂提取物为活性成分,加上化妆品中可接受的辅料制备而成的化妆品。
5.根据权利要求4所述的联合用药物,其特征在于:所述外用产品为面膜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810524286.1A CN108543044B (zh) | 2018-05-28 | 2018-05-28 | 一种治疗痤疮的联合用药物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810524286.1A CN108543044B (zh) | 2018-05-28 | 2018-05-28 | 一种治疗痤疮的联合用药物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108543044A CN108543044A (zh) | 2018-09-18 |
CN108543044B true CN108543044B (zh) | 2021-05-07 |
Family
ID=63511330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810524286.1A Active CN108543044B (zh) | 2018-05-28 | 2018-05-28 | 一种治疗痤疮的联合用药物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108543044B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109394666A (zh) * | 2018-12-06 | 2019-03-01 | 广州市诺兰精细化工有限公司 | 一种针对皮肤炎症的中药面膜及制备方法 |
CN113332215A (zh) * | 2021-07-23 | 2021-09-03 | 王涛 | 一种治疗痤疮抗过敏的组合物制剂及制备工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083580A (zh) * | 2013-02-26 | 2013-05-08 | 苏州市洋海电子有限公司 | 一种药物配方 |
CN104739979A (zh) * | 2013-12-26 | 2015-07-01 | 吕奎荣 | 一种内外兼治痤疮的中药 |
CN105412415A (zh) * | 2015-12-21 | 2016-03-23 | 荥阳市藤本保健品有限公司 | 祛痤疮的药物组合物 |
CN108014216A (zh) * | 2016-11-02 | 2018-05-11 | 吴海燕 | 一种消除脓包型青春痘的配方 |
-
2018
- 2018-05-28 CN CN201810524286.1A patent/CN108543044B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083580A (zh) * | 2013-02-26 | 2013-05-08 | 苏州市洋海电子有限公司 | 一种药物配方 |
CN104739979A (zh) * | 2013-12-26 | 2015-07-01 | 吕奎荣 | 一种内外兼治痤疮的中药 |
CN105412415A (zh) * | 2015-12-21 | 2016-03-23 | 荥阳市藤本保健品有限公司 | 祛痤疮的药物组合物 |
CN108014216A (zh) * | 2016-11-02 | 2018-05-11 | 吴海燕 | 一种消除脓包型青春痘的配方 |
Non-Patent Citations (5)
Title |
---|
中药活血化淤倒模法治疗痤疮色素斑;陈淑芬等;《临床军医杂志》;19911230;第19卷(第04期);全文 * |
中药面膜结合针罐法治疗痤疮临床观察;樊星等;《中国医药导报》;20060825;第03卷(第24期);第114页左栏第5-6段 * |
清肺愈痤方合复方颠倒散治疗痤疮150例疗效观察;赖梅生等;《新中医》;20121005;第44卷(第10期);全文 * |
温阳法在皮肤病治疗中的应用体会-附验案4则;窦海忠;《江苏中医药》;20100905;第42卷(第9期);第53页右栏第6-10段,第54页左栏倒数第6段 * |
痤消膏外治痤疮54例疗效观察;王醊恩等;《长春中医药大学学报》;20100410;第26卷(第02期);第244页左栏第1-8段 * |
Also Published As
Publication number | Publication date |
---|---|
CN108543044A (zh) | 2018-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101185717B (zh) | 治疗急慢性肠胃炎和肠胃溃疡的中药 | |
CN102018937A (zh) | 一种治疗痤疮的药物及制备方法 | |
CN102370949A (zh) | 一种治疗胆囊炎的中药复方制剂及其制备方法 | |
CN103830632A (zh) | 一种根治银屑病等多种皮肤病的中药制剂及其制备方法与应用 | |
CN108543044B (zh) | 一种治疗痤疮的联合用药物及其用途 | |
CN102935133B (zh) | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 | |
CN103341079A (zh) | 一种治疗粉刺的中药组合物 | |
CN101708297A (zh) | 一种治疗痛风病的药物 | |
CN102727779B (zh) | 一种治疗卵巢囊肿的药物组合物及其制备方法 | |
CN104258292A (zh) | 一种治疗妊娠合并症的妇产科药物及其制作方法 | |
CN100563705C (zh) | 一种治疗心脑血管疾病的中药及其制备方法 | |
CN104740583A (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
CN1172672A (zh) | 治疗癌症的中药组合物 | |
CN101239159B (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
CN102641373B (zh) | 一种用于治疗牛皮癣的中药组合物 | |
CN102935195B (zh) | 一种用于治疗冠心病的中药组合物及其制备方法和应用 | |
CN103599455B (zh) | 一种用于祛斑的中药胶囊 | |
CN102416126A (zh) | 一种治疗白塞氏病的中药组合剂及其制备方法 | |
CN102552537B (zh) | 一种用于治疗气血亏损的中药组合物 | |
CN108392620B (zh) | 一种治疗皮炎的联合用产品及其用途 | |
CN101543577A (zh) | 一种治疗青春痘的中药组合及其制备方法 | |
CN106110048A (zh) | 一种治疗痤疮的药物组合物 | |
CN103157035A (zh) | 一种治疗慢性浅表性胃炎的中药组合物 | |
CN102178893B (zh) | 一种用于治疗痤疮的复方药物 | |
CN101987188B (zh) | 一种用于预防和治疗高血脂症的生物中成药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |